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with metformin increased transepithelial resistance and 
reduced the sugar-dependent growth of S. aureus. Thus, 
epithelial paracellular permeability and glucose transport 
mechanisms are vital to maintain low glucose concentra-
tion in ASL and limit bacterial nutrient sources as a defence 
against infection.
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Introduction
Increased risk of Staphylococcus aureus infection in the 
respiratory tract is associated with hyperglycaemia [1, 
2]. Diabetes is a risk factor for nasal colonisation with S. 
aureus [3], increased pathogen load in cystic fibrosis (CF) 
[4, 5] and increased exacerbation frequency in people with 
chronic obstructive pulmonary disease (COPD) [1, 6].In an 
intensive care unit, patients with hyperglycaemia had more 
S. aureus in sputum and this was associated with increased 
glucose concentration in the thin layer of fluid that lines the 
airways (airway surface liquid, ASL) [2].
Glucose concentration in human ASL is normally much 
lower than that of blood at ~0.4 mM, [7–9]. However, ASL 
glucose concentrations are elevated in people with respira-
tory disease including acute viral rhinitis [10], COPD [1] 
and CF [9]. ASL glucose concentrations are also increased 
in experimental [11] and diabetic hyperglycaemia [10] and 
are further increased in people with both respiratory dis-
ease and diabetes [5, 9].
We developed an in vitro model of airway glucose 
homeostasis and showed that, under normal conditions, 
glucose predominantly diffuses from blood/interstitial fluid 
Abstract Hyperglycaemia as a result of diabetes mellitus 
or acute illness is associated with increased susceptibility 
to respiratory infection with Staphylococcus aureus. Hyper-
glycaemia increases the concentration of glucose in airway 
surface liquid (ASL) and promotes the growth of S. aureus 
in vitro and in vivo. Whether elevation of other sugars in 
the blood, such as fructose, also results in increased con-
centrations in ASL is unknown and whether sugars in ASL 
are directly utilised by S. aureus for growth has not been 
investigated. We obtained mutant S. aureus JE2 strains with 
transposon disrupted sugar transport genes. NE768(fruA) 
exhibited restricted growth in 10 mM fructose. In H441 air-
way epithelial-bacterial co-culture, elevation of basolateral 
sugar concentration (5–20 mM) increased the apical growth 
of JE2. However, sugar-induced growth of NE768(fruA) 
was significantly less when basolateral fructose rather than 
glucose was elevated. This is the first experimental evi-
dence to show that S. aureus directly utilises sugars pre-
sent in the ASL for growth. Interestingly, JE2 growth was 
promoted less by glucose than fructose. Net transepithe-
lial flux of d-glucose was lower than d-fructose. However, 
uptake of d-glucose was higher than d-fructose across both 
apical and basolateral membranes consistent with the pres-
ence of GLUT1/10 in the airway epithelium. Therefore, we 
propose that the preferential uptake of glucose (compared 
to fructose) limits its accumulation in ASL. Pre-treatment 
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across the respiratory epithelium into the ASL via paracel-
lular pathways, and this is limited by epithelial permeabil-
ity [8, 12–15]. Uptake via apical and basolateral GLUT 
transporters also restricts glucose accumulation in ASL 
[12–16] and rapid metabolism of glucose helps to main-
tain low intracellular glucose concentrations. This provides 
a driving force for glucose uptake and limits the transcel-
lular transport of glucose, leading to equilibrated ASL and 
intracellular glucose concentrations [13, 14]. In this model, 
increasing the diffusion gradient for glucose across the epi-
thelium (e.g. hyperglycaemia) and increasing paracellular 
diffusion of glucose via reduced transepithelial resistance 
(RT) (e.g. inflammation) result in elevated ASL glucose 
concentration [12, 13, 17].
We have shown that S. aureus growth is promoted by 
glucose in microbial culture [5] and that basolateral hyper-
glycaemia promotes apical growth of S. aureus in air-
way epithelial co-culture [12, 18]. S. aureus can also uti-
lise other sugars such as fructose. This sugar has recently 
received much attention, as it is included as a sweetener in 
many drinks. In a study of 39 clinical samples, plasma fruc-
tose levels were lower than glucose, 46 ± 25 µM compared 
to 6.19 ± 2.72 mM, but can reach 300 µM particularly after 
ingestion of high-fructose corn syrup [19, 20]. A high-fruc-
tose diet has been shown to lead to insulin insensitivity and 
accelerate the development of type II diabetes in rats [21–
23]. Elevation of systemic fructose could therefore contrib-
ute to the hyperglycaemia-induced growth of S. aureus in 
the airways. It is not known if fructose crosses the lung epi-
thelial cell membrane into ASL where it could provide an 
additional growth substrate for S. aureus. Moreover, there 
is also no evidence that sugars present in ASL (e.g. glucose 
or fructose) are directly utilised by S. aureus for growth.
We therefore investigated how glucose and fructose 
modified growth of S. aureus carbohydrate transporter 
mutants in microbial and airway epithelial co-culture. Our 
data indicate that fructose, in addition to glucose, crosses 
the airway epithelial barrier and that sugars in ASL are 
utilised by S. aureus to promote growth. In addition, our 
data indicate that transport of glucose and fructose by 
airway epithelial cells decreased the transepithelial flux 
of these sugars. The preferential uptake of glucose over 
fructose also sheds light on the identity of GLUT transport-
ers involved.
Methods
Bacterial culture
S. aureus JE2 is a USA300 community-associated methi-
cillin-resistant S. aureus used as the parent in construction 
of the Nebraska sequence-defined transposon insertion 
library [24]. JE2 and five transposon library mutants with 
insertions in predicted glucose or fructose sugar transport 
pathway genes were obtained from the network on antimi-
crobial resistance in Staphylococcus aureus (NARSA) and 
are listed in Table 1. For microbial culture, JE2 strains were 
inoculated into brain heart infusion broth (BHI) and grown 
overnight at 37 °C. The following day, the culture was 
diluted to an OD540 of 0.05 using RPMI. Then, 100 µl of 
this adapted culture was added into either 20 ml of glucose-
free RPMI, RPMI + 10 mM glucose or RPMI + 10 mM 
fructose. Cultures were incubated in a shaking water bath 
at 37 °C and 80 rpm for 24 h. OD measurements were 
taken every hour up to 8 h then again at 24 h. Samples were 
also removed for Miles and Misra quantification of colony 
forming units (CFU) on BHI agar. Plates were incubated 
overnight at 37 °C and CFU counted the following day.
For airway epithelial co-culture, a single colony of S. 
aureus strain JE2 or mutant was incubated overnight at 
37 °C in RPMI media containing glucose or fructose. The 
following day, fresh media was inoculated with 200 μl 
of the overnight culture and grown at 37 °C to log phase, 
OD540 of 0.5 (approximately 2 × 107 CFU/ml).
H441 airway epithelial cell culture and in vitro co-culture 
model
H441 epithelial cells were grown on permeable membrane 
supports (Transwells, Corning, MA, USA) at air–liquid 
interface to form lung epithelial cell layers, as previously 
described [12]. Monolayers were pre-treated with vehicle 
or 1 mM metformin (added to the basolateral medium) 18 h 
Table 1  S. aureus parent and mutant strains from the Nebraska sequence-defined transposon library [22]
Strain name Transposon insertion site Gene description Accession number
JE2 No mutation Parent strain
NE39(ptsG) ptsG Phosphotransferase system, glucose-specific II ABC component SAUSA 300_247C
NE768 fruA Fructose-specific permease SAUSA 300_0685
NE172 ptsG Phosphotransferase system, glucose-specific II BC component domain protein SAUSA 300_0191
NE1944 crr Phosphotransferase system, glucose-specific II A component SAUSA 300_1315
NE1405 gluC Probable glucose uptake protein SAUSA 300_2210
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prior to apical inoculation with S. aureus. Monolayer tran-
sepithelial resistance (RT) was measured using an epithelial 
volt ohmmeter (EVOM; World Precision Instruments, UK). 
For resistance measurements and bacterial co-cultures, the 
basolateral side of H441 monolayers was bathed in Krebs 
salt solution (in mM): NaCl, 117; NaHCO3, 25; KCl, 4.7; 
MgSO4, 1.2; KH2PO4, 1.2; CaCl2, 2.5 (equilibrated with 
5 % CO2 to pH 7.3–7.4), containing 5 mM glucose or 
20 mM glucose or 5 mM glucose + 15 mM fructose.
S. aureus cultures were diluted in glucose-free RPMI 
media and approximately 5 × 105 CFU of bacteria in 50 μl 
was applied to the apical surface of H441 monolayers. 
H441-S. aureus co-cultures were placed in a CO2 incuba-
tor at 37 °C for 7 h, after which each was homogenised and 
CFU calculated by plating out serial dilutions.
Paracellular flux and uptake experiments
Paracellular movement of glucose and fructose across 
H441 monolayers was measured by analysis of radiola-
belled [14C]-l-glucose, [14C]-d-glucose and [14C]-d-fruc-
tose transepithelial flux. Experiments were initiated by 
adding 0.5 ml of Krebs salt solution containing 1.0 μCi 
of radiolabeled sugar plus non-radiolabelled d-glucose 
(5 mM) and d-fructose (5 mM) to the basolateral side of 
the transwells and 0.1 ml of sugar-free Krebs solution to 
the apical side. Apical and basolateral samples were taken 
after 1 h and the concentration of radiolabelled glucose was 
analysed using a scintillation counter. For [14C]-d-glucose 
and [14C]-d-fructose experiments, paracellular flux was cal-
culated by compensating for total monolayer uptake.
Uptake experiments on H441 monolayers were initiated 
by replacing the medium with 0.5 ml transport medium 
containing 1.0 μCi of [14C]-d-glucose or [14C]-d-fructose 
plus 5 mM of non-radiolabelled equivalent d-glucose and 
d-fructose, to either the basolateral or apical side of the 
monolayer, followed by incubation at room temperature for 
10 min. Preliminary experiments indicated that the uptake 
was linear between 0 and 10 min (data not shown). Uptake 
was terminated by adding 2 ml ice-cold stop solution 
(15 mM HEPES buffer (pH 7.6); 135 mM choline Cl; 5 mM 
KCl; 0.8 mM MgSO4; 1.8 mM CaCl2 and 0.2 mM HgCl2). 
The cells were then rinsed twice with 2 ml stop solution and 
lysed in 0.5 ml of 10 mM Tris–HCl (pH 8.0) with 0.2 % 
SDS. Lysed samples were added to 2 ml scintillation cock-
tail and radio-active emissions determined using a scintilla-
tion counter to quantify glucose and fructose uptake.
Chemicals and reagents
All chemicals and reagents were obtained from Sigma, 
Poole, UK unless otherwise stated.
Statistical analysis
Values are reported as mean ± SEM. Statistical analysis 
was performed using analysis of variance (ANOVA) and 
post hoc Bonferroni multiple comparison or Student’s t 
test. p values of <0.05 were considered significant.
Results
Growth of S. aureus mutants in glucose and fructose
The growth curves of parent strain JE2 and the 5 iso-
genic mutants NE39(ptsG), NE768(fruA), NE1944(crr), 
NE172(ptsG) and NE1405(gluC) were characterised over 
24 h. To identify genes important for S. aureus sugar 
uptake and growth, the growth of all isogenic mutants was 
compared to JE2 under three conditions: RPMI medium, 
RPMI supplemented with 10 mM glucose and RPMI sup-
plemented with 10 mM fructose.
The Log10OD540 indicated that the growth of all six 
strains in RPMI in the absence of sugar was heavily 
restricted up to 8 h (Supplemental Figure 1). There was an 
observed increase in the Log10OD540 at 24 h of all strains. 
Importantly, there was no striking difference in the growth 
of each isogenic strain compared to JE2 parent strain, indi-
cating that gene disruptions did not impact growth in the 
absence of sugar.
In the presence of 10 mM glucose, the Log10OD540 for all 
strains was increased during lag phase and isolates began log 
phase by 6 h (Supplemental Figure 1). Strain NE39(ptsG) 
had the same growth characteristics as the parent strain JE2 
but strains NE768(fruA), NE1944(crr), NE172(ptsG) and 
NE1405(gluC)were observed to grow more slowly than the 
parent strain JE2 between 7 and 8 h. After 24 h, all 6 strains 
reached a similar Log10OD540, which was higher than in 
RPMI alone (Supplemental Figure 1).
In the presence of 10 mM fructose, the early Log10OD540 
for all strains was lower than in glucose. All strains except 
NE768(fruA) began log phase by 6 h(Supplemental Fig-
ure 1). NE768(fruA) growth was noticeably less than the 
JE2 parent strain after 7 and 8 h (n = 2 each strain). After 
24 h, all 6 strains reached a similar Log10OD540, which was 
higher than in RPMI alone (0.276 ± 0.002 compared to 
0.177 ± 0.005, respectively, p < 0.0001, n = 6).
From these first observational experiments, we then 
focussed our studies on NE768 (fruA fructose transporter 
mutant) and the parent strain JE2.
The growth of JE2 was similar in both 10 mM glucose 
and fructose (p > 0.05, n = 5, Fig. 1c–f). NE768(fruA) 
exhibited similar growth to JE2 in 10 mM glucose (p > 0.05, 
n = 5, Fig. 1c, d). However, the growth of NE768(fruA) 
was significantly inhibited compared to JE2 when grown in 
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10 mM fructose, Log10OD540 at 8 h was 0.014 ± 0.006 and 
0.181 ± 0.02, respectively (p < 0.0001, n = 5, Fig. 1e).Via-
ble counts confirmed 10 mM glucose-induced similar growth 
of JE2 and NE768(fruA) (p > 0.05, n = 5, Fig. 1d), while 
viable counts of JE2 in fructose at 8 h were significantly 
higher than NE768(fruA) (Log10 CFU was 8.14 ± 0.06 and 
7.05 ± 0.20, respectively; p < 0.0001, n = 5, Fig. 1f). These 
data confirmed that mutation of the fruA gene impacted the 
ability of strain NE768(fruA) to utilise fructose.
Effect of sugar on transepithelial resistance (RT)
In our co-culture model, we firstly determined whether 
changing the glucose or fructose concentration of baso-
lateral solution bathing the H441 airway epithelial cells 
could adversely affect transepithelial electrical resist-
ance (RT), as we previously found that high concentra-
tions of glucose impaired Calu-3 airway epithelial mon-
olayer resistance [15]. Supplementation with 2–20 mM 
glucose had no significant effect on RT in H441 cells 
grown at air–liquid interface over a time period of 7 h 
(p > 0.05, n = 5, Fig. 2). However, H441 RT was only 
stable with high concentrations of fructose (10–20 mM). 
RT declined significantly when the glucose concentra-
tion was reduced to 1 mM (p < 0.05, n = 5), or fructose 
was lowered to 5 mM (p < 0.05, n = 5). To avoid sugar-
induced changes in RT during H441-S. aureus co-culture 
experiments, the basolateral solution contained 5 mM 
glucose(control), which was then supplemented with 
15 mM glucose or fructose to measure sugar-induced 
bacterial growth.
Effect of elevation of basolateral glucose or fructose 
concentration on the apical growth of JE2 or NE768(fruA) 
in epithelial-bacterial co-culture
Increasing the basolateral glucose concentration from 5 
to 20 mM increased the growth of JE2 and NE768(fruA) 
on the apical surface of H441 airway epithelial monolay-
ers after 7 h (p < 0.05, n = 5, Fig. 3a). Addition of 15 mM 
fructose (plus 5 mM glucose) to the basolateral chamber 
also increased the apical growth of JE2 (p < 0.05, n = 5). 
Fig. 1  Growth of mutant S. 
aureus strains in the presence of 
glucose and fructose. Growth of 
S. aureus parent strain (JE2) and 
mutant strains NE768(fruA), 
NE172(ptsG), NE1944(crr) 
measured as OD540 or viable 
cell assay (CFU/ml) over 24 h, 
in glucose-free RPMI (a, b), 
RPMI supplemented with 
10 mM glucose (c, d) or RPMI 
supplemented with 10 mM 
fructose (e, f), n = 5. *p < 0.05, 
****p < 0.0001, compared to 
JE2
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However, the fructose-induced growth of NE768(fruA)was 
significantly less than that of JE2 (p < 0.01, n = 5). These 
data indicate that S. aureus directly utilises sugars in the 
ASL for growth. Analysis of sugar-induced growth in the 
epithelial-bacterial co-cultures also indicated that fructose 
induced more growth of JE2 than glucose (p < 0.05, n = 5, 
Fig. 3a). This was in contrast to JE2 growth in the presence 
of these two sugars in microbial culture (p > 0.05, n = 10, 
Fig. 3b).
Fructose and glucose uptake and transepithelial flux 
across airway epithelial monolayers
A comparison of d-fructose and d-glucose uptake by H441 
monolayers revealed that fructose uptake was significantly 
less than glucose across both apical and basolateral mem-
branes (p < 0.01 and p < 0.001, respectively; n = 8, Fig. 4a, 
b).
The rate of basolateral-to-apical net transepithelial flux 
of d-glucose was lower than that of l-glucose (not trans-
ported or metabolised) (p < 0.01, n = 4, Fig. 4c) and lower 
than that of d-fructose (p < 0.05, n = 4). Given that net flux 
of sugars = transepithelial flux − uptake, we calculated 
transepithelial flux for glucose and fructose. We found that 
calculated transepithelial flux was similar for glucose and 
fructose indicating that both similarly cross the epithelium 
(p > 0.05, n = 4, Fig. 4d). Moreover, these values were 
also similar to that of l-glucose which is not transported 
or metabolised (Fig. 4c, d). Thus, the difference in the rate 
of apical appearance of d-fructose and d-glucose could be 
accounted for by the difference in uptake of the two sugars.
Effect of metformin on fructose-induced bacterial growth
We previously showed that apical addition of S. aureus 
decreased transepithelial resistance and increased paracel-
lular permeability to glucose [18]. In these experiments, 
apical addition of S. aureus also significantly increased the 
rate of basolateral-to-apical flux of d-fructose (p < 0.01, 
n = 4, Fig. 5a). Moreover, we previously found that pre-
treatment of H441 airway epithelial monolayers cells with 
1 mM metformin attenuated S. aureus-induced changes 
in the paracellular flux of glucose and reduced glucose-
induced apical S. aureus growth. In the current study, 
metformin pre-treatment of the epithelium also reduced 
fructose-induced S. aureus growth, consistent with para-
cellular movement of fructose into the ASL providing a 
stimulus for bacterial growth (p < 0.05, n = 4, Fig. 5b). In 
Fig. 2  Sugar-induced changes in transepithelial electrical resistance 
across airway monolayers. Transepithelial resistance (RT) across 
H441 monolayers after 24 h incubation with basolateral Krebs salt 
solution supplemented with 1, 2, 5, 10, 15, 20 mM glucose or fruc-
tose, n = 5. *p < 0.05 compared to 2 mM glucose, 5 mM glucose, 
15 mM glucose, 20 mM glucose, 15 mM fructose and 20 mM fruc-
tose
Fig. 3  Apical S. aureus growth on airway epithelial monolayers is 
dependent on basolateral sugar concentration. a H441 airway epithe-
lia-bacteria co-cultures were grown in basolateral Krebs salt solution 
supplemented with 5 mM glucose (control), 20 mM glucose (glu-
cose-induced growth) or 5 mM glucose + 15 mM fructose (fructose-
induced growth). S. aureus JE2 and NE768(fruA)CFU were measured 
7 h post infection (% increase compared to growth in the presence of 
5 mM basolateral glucose), n = 5. *p < 0.05, **p < 0.01. b Increase 
in the number of JE2 and NE768(fruA) S. aureus (CFU/ml) in micro-
bial culture over 7 h in the presence of 10 mM glucose or 10 mM 
fructose, compared to glucose-free control, n = 10. *p < 0.05 com-
pared to all other bars
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support of this concept, it should be noted that metformin 
was removed and the epithelial cells were washed prior to 
the addition of bacteria in co-culture experiments. Further-
more, metformin had no direct effect on S. aureus growth 
in microbial culture (n = 3, Supplemental Figure 2).
Discussion
We previously showed that elevation of basolateral glucose 
promoted the growth of apical/luminal S. aureus in an in 
vitro model of human airway and that hyperglycaemia pro-
moted the growth of S. aureus in mouse airway [18].We 
showed that more glucose crossed the epithelial barrier into 
ASL under these conditions and we proposed that this pro-
vided a nutrient source for S. aureus [18].
Glucose and other sugars are growth substrates for res-
piratory pathogens such as S. aureus [25–27]. However, 
glucose may alter other factors in ASL such as the secre-
tion of antimicrobial proteins [28]. Glucose is also a known 
trigger for regulatory pathways in S. aureus, altering meta-
bolic pathways, expression of virulence factors, and biofilm 
production [29, 30].
In this study, we wanted to show that sugars present in 
ASL were taken up and utilised by S. aureus for growth. 
To do this, we used five previously uncharacterized iso-
genic mutant strains of S. aureus JE2. A number of these 
strains contained disruptions of the putative phosphotrans-
ferase system (PTS) which catalyses the transport and 
phosphorylation of monosaccharides, disaccharides and 
other sugar derivatives in bacteria. The system is complex 
and consists of three functional units, IIA, IIB and IIC to 
which a number of microbial genes contribute. The crr 
gene is the structural gene for IIIGlc, a IIA component of 
the PTS, and the ptsG operon encodes glucose (IICBA) and 
glucoside-specific enzymes that are sugar permeases, deliv-
ering specific sugars to the PTS [31]. In E. coli crr mutants, 
only 2–3 % in vitro phosphorylation of methyl α-glucoside 
activity was retained [32]. Thus, we expected that disrup-
tion of these genes would have a potent effect on glucose 
uptake and growth in S. aureus. Instead, glucose promoted 
the growth of all mutants and growth of NE1944(crr) and 
NE172(ptsG) was only inhibited by ~10 and 20 %, respec-
tively, at 8 h. Our findings indicate that either transposon 
insertion did not lead to complete loss of function of crr 
and ptsG genes in S. aureus or, more likely, that other path-
ways provided routes for glucose uptake and metabolism 
in these mutants [33]. It is possible that the mannose PTS, 
EIIABCDMan, which has wide substrate specificity and can 
transport glucose, could provide such a substitute trans-
port system [34–36]. Alternatively, an independent glu-
cose uptake pathway may compensate for the mutations. 
NE1405(gluC) was modified in its glucose uptake protein 
glcU which may be independent of the PTS pathway. This 
mutant also grew well in the presence of glucose, presum-
ably because it is compensated by an intact PTS glucose 
uptake system.
NE768(fruA) carried a mutation in the fruA gene which 
encodes the putative fructose-specific permease that inter-
acts with the PTS. Fructose promoted the growth of all 
mutants tested, except NE768(fruA). Growth of this mutant 
was significantly suppressed for up to 8 h but reached 
Fig. 4  Transepithelial flux and 
uptake of glucose and fructose 
across airway epithelial mon-
olayers. a Uptake of 14C-d-glu-
cose and 14C-D-fructose across 
the apical membrane of H441 
monolayers, n = 8. b Uptake of 
14C-d-glucose and 14C-d-fruc-
tose across the basolateral 
membrane of H441 monolayers, 
n = 8. c Basolateral-to-apical 
transepithelial flux of d-glucose, 
d-fructose and l-glucose across 
H441 monolayers, measured 
by adding radiolabelled sugar 
to the basolateral surface and 
monitoring its appearance of the 
apical surface over 1 h, n = 4. d 
Calculated basolateral-to-apical 
transepithelial flux of d-glucose 
and d-fructose across H441 
monolayers, after compensa-
tion for epithelial uptake, 
n = 4. *p < 0.05, **p < 0.01, 
***p < 0.001
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similar levels to all other mutants at 24 h in microbial cul-
ture. These data indicate that fruA disruption led to an ina-
bility to efficiently utilise fructose for growth.
Because the glucose transporter mutations had little 
impact on bacterial growth, we used NE768(fruA) to iden-
tify whether fructose could cross the epithelial barrier and 
promote apical S. aureus growth. We found that elevation 
of basolateral fructose or glucose concentration promoted 
the apical growth of JE2 but only glucose effectively pro-
moted the growth of NE768(fruA). These findings indicate 
that fructose also diffuses across the epithelial barrier into 
ASL and key to our hypothesis, the growth of S. aureus 
was dependent on the ability of the bacteria to take up and 
metabolise fructose. This is the first experimental evidence 
to show that S.aureus directly utilises sugars present in the 
ASL.
We noted that apical growth of JE2 was greater when the 
concentration of basolateral fructose, rather than glucose, 
was raised in epithelial-bacterial co-culture. This was in 
contrast to bacterial culture, where there was no differ-
ence in fructose- or glucose-induced growth over a similar 
time period. We previously showed that glucose diffuses 
across the airway epithelium into ASL, but its concentra-
tion is kept low by epithelial glucose transport and metabo-
lism [12, 13, 16, 37]. Our data show that both glucose and 
fructose similarly diffused from the basolateral compart-
ment into ASL and that paracellular flux was increased by 
the presence of bacteria [18]. However, the basolateral and 
apical uptake of fructose by H441 cells was significantly 
lower than that of glucose. Since pharmacological inhibi-
tion of GLUT-mediated glucose uptake with phloretin led 
to increased apical accumulation of glucose [13], we pro-
pose that, in this experimental model, reduced fructose 
uptake resulted in increased accumulation of fructose in 
ASL providing more availability of nutrients for wild-type 
JE2 growth.
These data and our finding that the RT of epithelial mon-
olayers decreased in fructose concentrations lower than 
10 mM, but only in glucose concentrations lower than 
2 mM, also shed important light on the potential identity 
of glucose transporters (GLUTs) that regulate glucose 
uptake and ASL glucose concentration. We identified glu-
cose transporters GLUT2 and GLUT10 in H441 cells 
[15]. GLUT1 and GLUT10 were identified in primary 
human bronchiolar epithelial cells (HBE) [14]. GLUT2 
transports glucose and fructose with similar low affinity 
(Km ~ 15 mM) [38, 39]. GLUT1 and GLUT10 transport 
glucose with higher affinity (Km ~ 5.0 and 0.3 mM, respec-
tively), but do not transport fructose [40, 41]. Thus, the 
increased uptake of glucose compared to fructose points 
towards the involvement of GLUT1 and/or GLUT10 in this 
process. In our previous studies, we were unable to identify 
GLUT1 in H441 cells, but GLUT10 protein expression cor-
related with increased glucose uptake in response to pro-
inflammatory agents [12]. As GLUT10 is localised to the 
mitochondria in vascular smooth muscle cells [42, 43] and 
mutations of the SLC2A10 gene are associated with arte-
rial tortuosity syndrome [44], more work is now required 
to elucidate this potentially distinct role of GLUT10 in the 
airway.
Treatment of H441 cells with metformin inhibited both 
glucose-and fructose-induced growth of JE2 and was asso-
ciated with restoration of airway epithelial RT consistent 
with our previous findings [18]. Both glucose and fructose 
are similar sized, non-charged, hexose molecules. Thus, 
these data further support our model where by metformin 
reduced paracellular flux of sugars limiting their accumu-
lation in ASL and availability as nutrients for S. aureus 
growth [13].
In conclusion, we characterised a number of S. 
aureus carbohydrate transporter mutants and identified 
Fig. 5  Metformin reduced the transepithelial flux of fructose and 
inhibited fructose-induced S. aureus JE2 growth across airway epi-
thelial monolayers. a The effect of metformin pre-treatment of 
H441 airway epithelial monolayers (1 mM; 18 h pre-treatment) on 
the fructose-induced growth of apical S. aureus JE2. H441 airway 
epithelia-bacteria co-cultures were grown in basolateral Krebs salt 
solution supplemented with 5 mM glucose (control) or 5 mM glu-
cose + 15 mM fructose (fructose-induced growth). S. aureus CFU 
were measured 7 h post infection (% increase compared to growth 
in the presence of 5 mM basolateral glucose), n = 4. b Transepithe-
lial flux of fructose across untreated and metformin pre-treated H441 
monolayers, measured by adding radiolabelled d-fructose to the baso-
lateral surface and monitoring its appearance of the apical surface, 
n = 4. *p < 0.05, ***p < 0.001, compared to control
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NE768(fruA) (a fruA mutant) with a reduced ability to 
utilise fructose as a growth substrate. Use of this mutant 
in epithelial-bacterial co-culture showed that S. aureus 
directly utilised sugars present in ASL for growth. Both 
fructose and glucose diffuse across the airway epithe-
lium into ASL. However, epithelial uptake of fructose is 
less than that of glucose. We propose this is because key 
transporters present in the airway epithelium preferentially 
transport glucose (e.g. GLUT1/10). This decreases the 
diffusion gradient for paracellular movement of glucose 
compared to fructose and more effectively removes glu-
cose from ASL. Given that blood glucose concentrations 
are much higher than fructose in vivo, glucose rather than 
fructose is more important as a bacterial nutrient source 
and preferential transport mechanisms would therefore 
be physiologically relevant. Consistent with our previous 
study, metformin significantly raised RT and reduced the 
sugar-dependent growth of S. aureus. Thus, epithelial par-
acellular permeability and glucose transport mechanisms 
are vital to maintaining low glucose concentration in ASL 
and limiting bacterial nutrient sources as a defence against 
infection.
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